NFKB (p100) (C-term S866/870), 848-874 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-NFKB (p100) (C-term S866/870), 848-874 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | NFKB (p100) (C-term S866/870), 848-874 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human (predicted reactivity: mouse) |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.5 |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This NFKB(p100) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 848-874 amino acids from the C-terminal region of human NFKB(p100). NF-kappa-B has been detected in numerous cell types thatexpress cytokines, chemokines, growth factors, cell adhesionmolecules, and some acute phase proteins in health and in variousdisease states. NF-kappa-B is activated by a wide variety ofstimuli, such as cytokines, oxidant-free radicals, inhaledparticles, ultraviolet irradiation, and bacterial or viralproducts. Inappropriate activation of NF-kappa-B has been linked toinflammatory events associated with autoimmune arthritis, asthma,septic shock, lung fibrosis, glomerulonephritis, ath |
| Immunogen | n/a |
| Other Names | [Nuclear factor NF-kappa-B p100 subunit; DNA-binding factor KBF2; H2TF1; Lymphocyte translocation chromosome 10 protein; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2; Oncogene Lyt-10; Lyt10; Nuclear factor NF-kappa-B p52 subunit; NFKB2; LYT10] |
| Gene, Accession # | [NFKB2], Gene ID: 4791, NCBI: NP_001070962.1, UniProt: Q00653 |
| Catalog # | MBS9204912 |
| Price | $165, $370 |
| Order / More Info | NFKB (p100) (C-term S866/870), 848-874 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010) Potter, C., et al. Ann. Rheum. Dis. 69(7):1315-1320(2010) Schuurhof, A., et al. Pediatr. Pulmonol. 45(6):608-613(2010) Johnatty, S.E., et al. PLoS Genet. 6 (7), E1001016 (2010) : Keller, U., et al. BMC Cancer 10, 348 (2010) : |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies